Skip to main content
. 2019 Aug 30;13(2):357–363. doi: 10.1159/000502605

Table 1.

Comparing 3 reported cases of hepatotoxicity secondary to ibrutinib

Case No. 1 2 3
Underlying illness Chronic lymphocytic Waldenstrom's Waldenstrom's
leukemia macroglobulinemia macroglobulinemia
Age, years 62 59 77
Sex Male Female Female
Abnormal liver function test onset 2 weeks 36 weeks 8 weeks
ALT peak, U/L 1,245 ~800 1,747
AST peak, U/L 448 ~3,000 1,300
Total bilirubin peak, mg/dL 35.2 13.6 20.4
INR peak Not specified 7.7 1.5
Liver biopsy Hepatocellular injury + Hepatocellular injury + Hepatocellular injury +
cholestasis cholestasis cholestasis
Recovery time 12 weeks + 9 weeks 7 weeks
Outcome Died from original illness Full recovery Full recovery